4 months ago
NAGE
AnalystsRaghuram SelvarajuRaghuram Selvaraju's Stock Forecasts
AnalystsRaghuram Selvaraju
Analyst Ranking
Top 2%
#51 out of 4935 analysts
Average Return
+7.44%
Win Rate
42%424 out of 1005
Risk vs Reward
Poor
Good
Raghuram Selvaraju's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Moonlake ImmunotherapeuticsMLTX | +713.02% | $6.91 | $56.18 | 2022-07-21 - 2023-07-20 | Buy |
Cormedix IncCRMD | +677.78% | $0.90 | $7.00 | 2018-05-23 - 2019-05-23 | Buy |
Anavex Life Sciences CorpAVXL | +547.79% | $2.49 | $16.13 | 2020-03-16 - 2021-03-16 | Buy |
Verona Pharma PLCVRNA | +511.40% | $15.44 | $94.40 | 2024-06-27 - 2025-06-26 | Buy |
Verona Pharma PLCVRNA | +509.80% | $15.51 | $94.58 | 2024-07-01 - 2025-06-30 | Buy |
Raghuram Selvaraju Analyst Color
Get additional color on Raghuram Selvaraju's coverage of popular stocks
5 months ago
PLX
2 years ago
CING
3 years ago
OBSVF
Raghuram Selvaraju's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Urogen Pharma LtdURGN | 31 | Buy | $50.00 | +241.53% | Reiterates | 3 days ago |
Gain Therapeutics IncGANX | 22 | Buy | $8.00 | +351.98% | Reiterates | 8 days ago |
Aardvark Therapeutics IncAARD | 1 | Buy | $40.00 | +217.46% | Initiates Coverage On | 11 days ago |
Processa Pharmaceuticals IncPCSA | 9 | Buy | $2.00 | +769.57% | Maintains | 11 days ago |
Cognition Therapeutics IncCGTX | 9 | Buy | $3.00 | +328.57% | Reiterates | 15 days ago |
Aclaris Therapeutics IncACRS | 13 | Buy | $16.00 | +906.29% | Reiterates | 16 days ago |
Bioxcel Therapeutics IncBTAI | 38 | Buy | $8.00 | +300.00% | Maintains | 18 days ago |
Septerna IncSEPN | 1 | Buy | $26.00 | +122.60% | Initiates Coverage On | 18 days ago |
Cocrystal Pharma IncCOCP | 15 | Buy | $6.00 | +282.17% | Maintains | 21 days ago |
Aquestive Therapeutics IncAQST | 27 | Buy | $10.00 | +148.14% | Reiterates | 24 days ago |
Brainsway LtdBWAY | 22 | Buy | $16.00 | +26.63% | Reiterates | a month ago |
Omeros CorpOMER | 5 | Buy | $9.00 | +160.12% | Initiates Coverage On | a month ago |
Axsome Therapeutics IncAXSM | 34 | Buy | $180.00 | +62.56% | Reiterates | a month ago |
Coya Therapeutics IncCOYA | 3 | Buy | $18.00 | +184.58% | Reiterates | a month ago |
Annovis Bio IncANVS | 19 | Buy | $12.00 | +321.05% | Maintains | a month ago |
Bridgebio Pharma IncBBIO | 23 | Buy | $56.00 | +21.03% | Maintains | a month ago |
Verona Pharma PLCVRNA | 22 | Buy | $90.00 | -14.16% | Maintains | a month ago |
Ovid Therapeutics IncOVID | 10 | Buy | $1.50 | +258.00% | Maintains | a month ago |
Sarepta Therapeutics IncSRPT | 2 | Hold | $40.00 | +109.81% | Reiterates | 2 months ago |
Fennec Pharmaceuticals IncFENC | 13 | Buy | $13.00 | +43.81% | Reiterates | 2 months ago |
Entrada Therapeutics IncTRDA | 14 | Buy | $20.00 | +195.86% | Reiterates | 2 months ago |
Assertio Holdings IncASRT | 5 | Buy | $3.50 | +392.96% | Reiterates | 2 months ago |
Benitec Biopharma IncBNTC | 3 | Buy | $28.00 | +103.05% | Reiterates | 2 months ago |
Alpha Cognition IncACOG | 4 | Buy | $20.00 | +81.82% | Reiterates | 2 months ago |
Vanda Pharmaceuticals IncVNDA | 8 | Buy | $20.00 | +300.80% | Reiterates | 2 months ago |
Repligen CorpRGEN | 8 | Buy | $180.00 | +34.33% | Reiterates | 2 months ago |
Abeona Therapeutics IncABEO | 11 | Buy | $20.00 | +241.88% | Maintains | 2 months ago |
Balchem CorpBCPC | 16 | Buy | $180.00 | +11.16% | Maintains | 2 months ago |
Soleno Therapeutics IncSLNO | 6 | Buy | $100.00 | +24.50% | Reiterates | 3 months ago |
Polypid LtdPYPD | 9 | Buy | $11.00 | +217.00% | Reiterates | 3 months ago |
Microbot Medical IncMBOT | 8 | Buy | $9.00 | +240.91% | Reiterates | 3 months ago |
Genmab AGMAB | 46 | Buy | $37.00 | +69.26% | Reiterates | 3 months ago |
Niagen Bioscience IncNAGE | 19 | Buy | $11.00 | -6.70% | Reiterates | 3 months ago |
Rhythm Pharmaceuticals IncRYTM | 10 | Buy | $80.00 | -10.15% | Reiterates | 3 months ago |
Anavex Life Sciences CorpAVXL | 25 | Buy | $42.00 | +275.67% | Reiterates | 3 months ago |
Emergent Biosolutions IncEBS | 6 | Buy | $15.00 | +104.64% | Reiterates | 3 months ago |
Rockwell Medical IncRMTI | 23 | Buy | $3.00 | +132.56% | Maintains | 4 months ago |
Enlivex Therapeutics LtdENLV | 13 | Buy | $7.00 | +422.39% | Maintains | 4 months ago |
Longeveron IncLGVN | 10 | Buy | $10.00 | +566.67% | Reiterates | 4 months ago |
Inovio Pharmaceuticals IncINO | 6 | Hold | $3.00 | +115.83% | Reiterates | 4 months ago |
Entera Bio LtdENTX | 16 | Buy | $10.00 | +443.48% | Reiterates | 4 months ago |
Regenxbio IncRGNX | 1 | Buy | $34.00 | +275.28% | Maintains | 4 months ago |
Regulus Therapeutics IncRGLS | 19 | Buy | $10.00 | +22.55% | Reiterates | 4 months ago |
Rapt Therapeutics IncRAPT | 18 | Buy | $80.00 | +828.07% | Reiterates | 4 months ago |
Cingulate IncCING | 5 | Buy | $20.00 | +351.47% | Reiterates | 4 months ago |
Moonlake ImmunotherapeuticsMLTX | 28 | Buy | $100.00 | +104.58% | Reiterates | 4 months ago |
Rani Therapeutics Holdings IncRANI | 1 | Buy | $9.00 | +1,263.64% | Reiterates | 5 months ago |
Protalix Biotherapeutics IncPLX | 6 | Buy | $15.00 | +913.51% | Maintains | 5 months ago |
Spero Therapeutics IncSPRO | 18 | Buy | $5.00 | +76.06% | Reiterates | 5 months ago |
Hoth Therapeutics IncHOTH | 8 | Buy | $4.00 | +168.46% | Reiterates | 6 months ago |
Reviva Pharmaceuticals Holdings IncRVPH | 15 | Buy | $11.00 | +2,706.12% | Maintains | 6 months ago |
Cervomed IncCRVO | 1 | Buy | $42.00 | +482.52% | Initiates Coverage On | 7 months ago |
Biolife Solutions IncBLFS | 3 | Buy | $27.00 | +18.84% | Maintains | 8 months ago |
Cardiff Oncology IncCRDF | 13 | Buy | $13.00 | +212.50% | Maintains | 8 months ago |
Adma Biologics IncADMA | 16 | Buy | $26.00 | +40.77% | Maintains | 8 months ago |
Scilex Holding CoSCLX | 7 | Buy | $245.00 | +3,675.04% | Reiterates | 9 months ago |
Indaptus Therapeutics IncINDP | 12 | Buy | $12.00 | -2.76% | Reiterates | 9 months ago |
Addex Therapeutics LtdADXN | 7 | Buy | $30.00 | +235.57% | Reiterates | 9 months ago |
Fate Therapeutics IncFATE | 4 | Hold | $5.00 | +331.03% | Reiterates | a year ago |
Arcadia Biosciences IncRKDA | 13 | Buy | $6.00 | +24.48% | Reiterates | a year ago |
Equillium IncEQ | 11 | Buy | $5.00 | +1,336.78% | Reiterates | a year ago |
Kezar Life Sciences IncKZR | 17 | Buy | $70.00 | +1,361.38% | Reiterates | a year ago |
Oncternal Therapeutics IncONCT | 11 | Buy | $18.00 | +3,315.56% | Maintains | a year ago |
Sol Gel Technologies LtdSLGL | 17 | Buy | $60.00 | N/A | Reiterates | a year ago |
Landos Biopharma IncLABP | 2 | Hold | $20.42 | N/A | Downgrades | a year ago |
Karuna Therapeutics IncKRTX | 15 | Hold | $330.00 | N/A | Maintains | a year ago |
Taro Pharmaceutical Industries LtdTARO | 8 | Hold | $43.00 | N/A | Downgrades | a year ago |
Eton Pharmaceuticals IncETON | 9 | Buy | $10.00 | N/A | Reiterates | 2 years ago |
Paxmedica IncPXMD | 1 | Buy | $3.00 | N/A | Initiates Coverage On | 2 years ago |
Spruce Biosciences IncSPRB | 7 | Buy | $10.00 | N/A | Reiterates | 2 years ago |
Cosciens Biopharma IncCSCI | 10 | Buy | $60.00 | N/A | Maintains | 2 years ago |
Ensysce Biosciences IncENSC | 2 | Buy | $105.00 | N/A | Maintains | 2 years ago |
Anebulo Pharmaceuticals IncANEB | 2 | Buy | $6.00 | N/A | Reiterates | 2 years ago |
Galecto IncGLTO | 4 | Buy | $50.00 | N/A | Maintains | 2 years ago |
Cartesian Therapeutics IncRNAC | 5 | Buy | $5.00 | N/A | Reiterates | 2 years ago |
Galera Therapeutics IncGRTX | 6 | Hold | $0.30 | N/A | Downgrades | 2 years ago |
Provention Bio IncPRVB | 6 | Hold | $25.00 | N/A | Downgrades | 2 years ago |
Tourmaline Bio IncTRML | 3 | Buy | $12.00 | N/A | Reiterates | 2 years ago |
Timber Pharmaceuticals IncTMBRQ | 4 | Buy | $50.00 | N/A | Maintains | 3 years ago |
Obseva SaOBSVF | 6 | Hold | N/A | N/A | Downgrades | 3 years ago |
Aptinyx IncAPTX | 2 | Buy | $1.00 | N/A | Maintains | 3 years ago |
Fresh Tracks Therapeutics IncFRTX | 2 | Buy | $4.50 | N/A | Maintains | 3 years ago |
Ayala Pharmaceuticals IncAYLA | 2 | Buy | $12.00 | N/A | Maintains | 3 years ago |
Evofem Biosciences IncEVFM | 8 | Buy | $4.00 | N/A | Maintains | 3 years ago |
Elicio Therapeutics IncELTX | 5 | Hold | N/A | N/A | Downgrades | 3 years ago |
Tyra Biosciences IncTYRA | 1 | Buy | $12.00 | N/A | Initiates Coverage On | 3 years ago |
Neubase Therapeutics IncNBSE | 4 | Buy | $200.00 | N/A | Maintains | 3 years ago |
Barinthus Biotherapeutics PLCBRNS | 1 | Buy | $22.00 | N/A | Maintains | 3 years ago |
Sorrento Therapeutics IncSRNEQ | 4 | Buy | $20.00 | N/A | Maintains | 3 years ago |
Oramed Pharmaceuticals IncORMP | 2 | Buy | $32.00 | N/A | Maintains | 4 years ago |
Inmed Pharmaceuticals IncINM | 1 | Buy | $3,000.00 | N/A | Initiates Coverage On | 4 years ago |
Gri Bio IncGRI | 1 | Buy | $12.00 | N/A | Initiates Coverage On | 4 years ago |
Synlogic IncSYBX | 3 | Buy | $105.00 | N/A | Maintains | 4 years ago |
Adamas Pharmaceuticals IncADMS | 2 | Hold | $9.10 | N/A | Downgrades | 4 years ago |
Redhill Biopharma LtdRDHL | 2 | Buy | $21,000.00 | N/A | Maintains | 4 years ago |
Itamar Medical LtdITMR | 3 | Hold | $31.00 | N/A | Downgrades | 4 years ago |
Immunic IncIMUX | 3 | Buy | $25.00 | N/A | Maintains | 4 years ago |
Acorda Therapeutics IncACORQ | 4 | Buy | $200.00 | N/A | Upgrades | 4 years ago |
Exicure IncXCUR | 2 | Buy | $900.00 | N/A | Maintains | 4 years ago |
Bausch Health Companies IncBHC | 4 | Buy | $55.00 | N/A | Maintains | 4 years ago |
Tff Pharmaceuticals IncTFFP | 2 | Buy | $925.00 | N/A | Maintains | 4 years ago |
Viela Bio IncVIE | 2 | Hold | $53.00 | N/A | Downgrades | 4 years ago |
Metavia IncMTVA | 2 | Buy | $3,840.00 | N/A | Maintains | 4 years ago |
Applied Dna Sciences IncAPDN | 5 | Buy | $210,000.00 | N/A | Maintains | 4 years ago |
Zosano Pharma CorpZSANQ | 2 | Buy | $2.50 | N/A | Maintains | 5 years ago |
Caredx IncCDNA | 3 | Buy | $40.00 | N/A | Maintains | 5 years ago |
Meridian Bioscience IncVIVO | 1 | Buy | $34.00 | N/A | Initiates Coverage On | 5 years ago |
Biospecifics Technologies CorpBSTC | 2 | Buy | $100.00 | N/A | Maintains | 5 years ago |
Cytodyn IncCYDY | 1 | Hold | N/A | N/A | Downgrades | 5 years ago |
Replimune Group IncREPL | 1 | Hold | $25.00 | N/A | Downgrades | 5 years ago |
Igm Biosciences IncIGMS | 1 | Buy | $88.00 | N/A | Initiates Coverage On | 5 years ago |
Evoke Pharma IncEVOK | 2 | Buy | $1,440.00 | N/A | Upgrades | 5 years ago |
Springworks Therapeutics IncSWTX | 1 | Buy | $60.00 | N/A | Upgrades | 5 years ago |
Stemline Therapeutics IncSTML | 1 | Buy | $18.00 | N/A | Maintains | 5 years ago |
Kala Bio IncKALA | 3 | Buy | $600.00 | N/A | Reiterates | 6 years ago |
Entero Therapeutics IncENTO | 2 | Buy | $7.00 | N/A | Maintains | 6 years ago |
Celcuity IncCELC | 1 | Buy | $36.00 | N/A | Initiates Coverage On | 7 years ago |
Cytomx Therapeutics IncCTMX | 1 | Buy | $32.00 | N/A | Initiates Coverage On | 7 years ago |
Cormedix IncCRMD | 2 | Buy | $10.00 | N/A | Maintains | 7 years ago |
Ladrx CorpLADX | 1 | Buy | $4.50 | N/A | Maintains | 7 years ago |
Check Cap LtdCHEK | 1 | Buy | $280.00 | N/A | Maintains | 7 years ago |
Oncosec Medical IncONCSQ | 2 | Buy | $880.00 | N/A | Maintains | 7 years ago |
T2 Biosystems IncTTOO | 2 | Buy | $42,500.00 | N/A | Maintains | 7 years ago |
Lisata Therapeutics IncLSTA | 1 | Buy | $12.00 | N/A | Maintains | 7 years ago |
Durect CorpDRRX | 2 | Buy | $35.00 | N/A | Upgrades | 7 years ago |
Dentsply Sirona IncXRAY | 3 | Hold | $63.00 | N/A | Maintains | 7 years ago |
Aethlon Medical IncAEMD | 1 | Buy | $3,600.00 | N/A | Initiates Coverage On | 8 years ago |
Kiora Pharmaceuticals IncKPRX | 1 | Buy | $5.00 | N/A | Maintains | 8 years ago |
Bio Path Holdings IncBPTH | 1 | Buy | $6,000.00 | N/A | Maintains | 8 years ago |
Immuron LtdIMRN | 1 | Buy | $15.00 | N/A | Initiates Coverage On | 8 years ago |
Foamix Pharmaceuticals LtdFOMX | 1 | Buy | $12.00 | N/A | Initiates Coverage On | 8 years ago |
Ocular Therapeutix IncOCUL | 1 | Buy | $10.00 | N/A | Initiates Coverage On | 8 years ago |
Alimera Sciences IncALIM | 1 | Strong Buy | $60.00 | N/A | Initiates Coverage On | 8 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.